Sun.Feb 16, 2025

article thumbnail

Vaccine Administration in Pharmacies, Nontraditional Clinics Could Help Increase Access

Drug Topics

Deck: In order to meet national targets, the United States should expand vaccination administration in complementary sites like pharmacies.

Vaccines 247
article thumbnail

Tax Savings For Pharmacy Owners

DiversifyRx

Tax Savings for Pharmacy Owners: What You Need to Know Taxes might not be the most exciting topic, but theyre crucial to your financial health as a pharmacy owner. Knowing how to navigate deductions, credits, and tax planning strategies can make a big difference in your bottom line. Every dollar saved on taxes is a dollar you can reinvest in your business or take home.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Grants Fast Track Designation to Amlenetug for Possible Treatment of Multiple System Atrophy

Pharmacy Times

Amlenetug could provide a treatment option for patients with multiple system atrophy, a progressive and rare condition that causes damage to the brains nerve cells.

FDA 73
article thumbnail

Opinion: The abrupt end of USAID-funded clinical trials is profoundly unethical

STAT

The path from the atrocities of Nuremberg and Tuskegee to today’s robust ethics of medical research has not been easy. In response to these horrific events, a remarkable global consensus emerged, across countries in very different parts of the world and with very different types of governments: Medical researchers, and the institutions and companies who fund their work, are bound by a series of ethical obligations.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

Pharmacy Times

DLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.

FDA 73
article thumbnail

5 Things You Need To Know About The Learn Antibiotics Book Of Games

IDStewardship

In this article insights are provided about the new book “Learn Antibiotics: Book of Games” which is available for purchase today on most Amazon marketplaces around the globe. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Posted17 February 2024 The book Learn Antibiotics: Book of Games was released for sale on Amazon in late 2024.

130
130

More Trending

article thumbnail

STAT+: Trump administration layoffs set to hit NIH are ‘devastating,’ former director Monica Bertagnolli says

STAT

Sweeping layoffs are set to hit federal health and science agencies , including at the National Institutes of Health, and former director Monica Bertagnolli called the situation at the NIH “devastating.” “We’re going to lose the next generation, that is the most difficult loss. This just sends, sends a chill,” Bertagnolli told STAT in an interview Saturday on the sidelines of the American Association for the Advancement of Science annual meeting in Boston.

article thumbnail

STAT+: FDA cuts hit AI division, even as Trump invests in the technology

STAT

WASHINGTON — The layoffs over the weekend at the Food and Drug Administration appear to have hit the AI and digital health staff particularly hard at a time when federal regulators are scrambling for ways to keep tabs on hospitals and insurers that are embracing the technologies. The terminations, with their potential to halt or hobble AI regulation, have caused alarm both inside and outside the agency, according to people interviewed by STAT.

FDA 145